#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	4438	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2395	540.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1570	1570	C	662	C	595	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7076	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4224	502.5	0	.	n	.	0	T695C	SNP	695	695	T	1379	1379	C	586	C,A,T	505,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7076	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4224	502.5	0	.	n	.	0	G1337A	SNP	1337	1337	G	2021	2021	A	570	A	517	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7076	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4224	502.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2655	2655	C	616	C,A	556,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7076	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4224	502.5	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3281	3281	T	593	T,C,A,G	541,2,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7076	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4224	502.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2729	2729	A	651	A,G	597,2	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	666	folP	852	852	100.0	folP.l15.c4.ctg.1	2045	97.5	1	SNP	p	R228S	1	.	.	682	684	AGC	1281	1283	AGC	128;129;130	A,G;G;C	112,1;118;119	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1394	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	4029	103.5	1	SNP	p	S91F	0	.	.	271	273	TCC	905	907	TCC	112;111;112	T;C,A;C	101;102,1;105	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1394	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	4029	103.5	1	SNP	p	D95N	0	.	.	283	285	GAC	917	919	GAC	113;113;111	G;A;C	106;106;99	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1394	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	4029	103.5	1	SNP	p	D95G	0	.	.	283	285	GAC	917	919	GAC	113;113;111	G;A;C	106;106;99	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	539	598	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1789	99.8	0	.	p	.	0	A39T	NONSYN	115	117	GCC	709	711	ACC	139;139;140	A;C;C	129;131;131	.	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	539	598	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1789	99.8	0	.	p	.	0	R44H	NONSYN	130	132	CGC	724	726	CAC	144;144;144	C;A;C	132;134;134	.	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	539	598	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1789	99.8	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	907	909	CAC	164;163;163	C;A;C	149;144;146	.	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	539	598	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1789	99.8	1	SNP	p	G45D	0	.	.	133	135	GGC	727	729	GGC	144;143;144	G;G;C	132;130;134	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	392	mtrR_promoter	250	250	100.0	mtrR_promoter.l6.c4.ctg.1	1612	72.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1412	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3405	123.4	1	SNP	p	D86N	0	.	.	256	258	GAC	858	860	GAC	145;145;145	G;A;C	129;127;131	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1412	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3405	123.4	1	SNP	p	S87I	0	.	.	259	261	AGT	861	863	AGT	146;146;144	A;G;T,G	126;133;128,1	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1412	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3405	123.4	1	SNP	p	S87R	0	.	.	259	261	AGT	861	863	AGT	146;146;144	A;G;T,G	126;133;128,1	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1412	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3405	123.4	1	SNP	p	S87W	0	.	.	259	261	AGT	861	863	AGT	146;146;144	A;G;T,G	126;133;128,1	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1412	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3405	123.4	1	SNP	p	S88P	0	.	.	262	264	TCC	864	866	TCC	145;145;145	T,C;C,G;C	126,1;129,1;127	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1270	parE	1986	1986	100.0	parE.l6.c4.ctg.1	3391	112.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1996	1998	GGC	168;167;167	G;G;C	145;147;149	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	1102	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3012	109.7	1	SNP	p	A311V	0	.	.	931	933	GCA	1528	1530	GCA	152;153;154	G;C;A,C	139;136;141,1	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1102	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3012	109.7	1	SNP	p	I312M	0	.	.	934	936	ATC	1531	1533	ATC	154;154;154	A;T;C	142;139;138	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1102	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3012	109.7	1	SNP	p	V316P	0	.	.	946	948	GTG	1543	1545	GTG	151;151;152	G,T;T;G	135,1;140;139	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1102	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3012	109.7	1	SNP	p	V316T	0	.	.	946	948	GTG	1543	1545	GTG	151;151;152	G,T;T;G	135,1;140;139	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1102	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3012	109.7	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2047	2049	ACC	129;129;128	A;C;C	113;113;115	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1102	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3012	109.7	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2101	2103	GCG	131;131;131	G;C,G;G,T	112;99,1;110,1	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1102	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3012	109.7	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2101	2103	GCG	131;131;131	G;C,G;G,T	112;99,1;110,1	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1102	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3012	109.7	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2224	2226	GGC	133;133;133	G;G;C	120;123;124	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1102	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3012	109.7	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2233	2235	GGC	135;135;134	G,C;G;C	117,1;119;120	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1102	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3012	109.7	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2251	2253	CCG	133;133;133	C,G;C;G	115,1;120;119	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	1512	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3724	121.7	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1939	1941	CTG	140;140;140	C;T,G;G	124;122,1;124	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	724	porA	1146	1146	99.83	porA.l6.c4.ctg.1	2478	87.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	921	921	C	113	C	102	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	770	porB1b	1035	1035	96.01	porB1b.l6.c4.ctg.1	1871	122.4	0	.	p	.	0	E48K	NONSYN	142	144	GAA	645	647	AAA	157;157;157	A;A;A	145;143;143	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	770	porB1b	1035	1035	96.01	porB1b.l6.c4.ctg.1	1871	122.4	0	.	p	.	0	T87A	NONSYN	259	261	ACT	762	764	GCT	164;163;162	G;C;T	152;151;153	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	770	porB1b	1035	1035	96.01	porB1b.l6.c4.ctg.1	1871	122.4	0	.	p	.	0	G189S	NONSYN	565	567	GGC	1068	1070	AGC	152;152;152	A;G;C	140;138;143	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	770	porB1b	1035	1035	96.01	porB1b.l6.c4.ctg.1	1871	122.4	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	1134	1134	T	174	T,A	150,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	770	porB1b	1035	1035	96.01	porB1b.l6.c4.ctg.1	1871	122.4	1	SNP	p	G120K	0	.	.	358	360	GGT	861	863	GGT	155;151;151	G;G;T	142;137;135	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	770	porB1b	1035	1035	96.01	porB1b.l6.c4.ctg.1	1871	122.4	1	SNP	p	A121D	0	.	.	361	363	GCC	864	866	GCC	152;154;155	G;C;C	134;141;140	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	770	porB1b	1035	1035	96.01	porB1b.l6.c4.ctg.1	1871	122.4	1	SNP	p	A121N	0	.	.	361	363	GCC	864	866	GCC	152;154;155	G;C;C	134;141;140	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2646	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5426	145.9	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2265	2267	AAT	156;156;156	A;A;T	145;144;144	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	444	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1569	85.0	1	SNP	p	V57M	1	.	.	169	171	ATG	762	764	ATG	167;167;165	A;T;G	153;154;156	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
